HomeNew
Latest
E-paper
Companies
Economy
Finance
Budget
Industry
Markets
External Affairs Defence Security
World News
Opinion
India News
Technology
Specials
Partner Content
Multimedia
sports
Cricket
Lifestyle
Entertainment
Social Viral
Health
BS Decoded
Books
Education
NewslettersNew
Video Gallery
WebstoriesNew
Politics
Management
Sudoku
Crossword
BS Apps
Explore Business Standard
BFSI Insight Summit
Events
About Us
BS Support
Popular Search
Don’t miss the latest developments in business and finance.
Russian oil & Opec effect: Outcome of buying Urals oil above cap are severe
Against popular belief, percentage of migrants have remained fairly stable
Asci seeks feedback on updating its guidelines for education ads
Statsguru: Six charts show fund flow to national-level political parties
Climate change insurance: Poor reach, reliance on fossil fuel key issues
Explained: Why Taiwanese giant Foxconn is clearly bullish about India
The spectre of coal over climate change as electricity demand soars
Deakin University's Indian teachers to get trained in Australia
High stakes: OYO, FHRAI accuse each other of functional irregularities
Why the Dakota DC-3 is important to aviation history in India and the world
Few women in India hold CFA charter; amid social pressures, lack of parity
RRR, Pathaan remind trade and studios of economic power of single screens
Explained: How sensitive is the issue of pledge of shares by promoters?
Over 5,500 dog bite cases a day in 2022, though lower than pre-Covid count
A sugar rush for emissions: Is ethanol-spiked fuel a sweet solution?
Statsguru: Six charts explain labour scars from Covid-19 pandemic
Indians spent a record amount on foreign travel in 2022. Here's how much
Explained: Why Indian consumers don't gain from Russian crude oil
Why this smallcap specialty chemicals stock zoomed 57% in 4 days? Details
Sales dip at 60% of Mumbai's offline grocery as quick commerce grows: Study
Draft data protection rules ₹ 1000 balance regulation, innovation: Vaishnaw
protection rules balance regulation, innovation: Vaishnaw
Weakening rupee may not be shot in the arm for India's pharma exporters